Press ReleasesFirst day of dealings on AIM1st February 2006 Not for release or distribution or publication in whole or part in or into the United States, Canada, Japan, Republic of Ireland or Australia Intercytex Group plc (“Intercytex” or the “Company”) Cambridge, UK, 1 February 2006 - Intercytex Group plc, a UK-based emerging healthcare company developing cell therapy products for the woundcare and aesthetic medicine markets, is pleased to announce that admission to trading on AIM will become effective, and dealings in the ordinary shares of the Company will commence, at 8.00am today, Wednesday, 1 February 2006, under the ticker symbol ICX.L. Piper Jaffray Ltd. is acting as nominated adviser and sole broker to the Company.
|